• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease.

作者信息

Morgan D J, McLean A J

机构信息

Department of Pharmaceutics, Victorian College of Pharmacy, Melbourne, Australia.

出版信息

Hepatology. 1991 Dec;14(6):1280-2.

PMID:1959879
Abstract
摘要

相似文献

1
Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease.慢性肝病中肝脏氧扩散受损的治疗意义
Hepatology. 1991 Dec;14(6):1280-2.
2
Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.慢性肝病和肝细胞癌患者中性粒细胞产生氧衍生自由基的能力受损。
Hepatology. 1994 Aug;20(2):326-30.
3
[Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease].[肝脏在糖尿病和慢性肝病中葡萄糖代谢调节中的作用]
Ann Ital Med Int. 1997 Apr-Jun;12(2):84-91.
4
[Hepatic diffusion of ceftriaxone].[头孢曲松的肝脏扩散]
Pathol Biol (Paris). 1986 Jun;34(5 Pt 2):559-60.
5
[Clevage of exogenous lipids in patients with chronic hepatic disease].[慢性肝病患者中外源性脂质的分解]
Vopr Pitan. 1969 Mar-Apr;28(2):11-6.
6
Relationship between serum and hepatic 7S fragments of type IV collagen in chronic liver disease.慢性肝病中血清与肝脏IV型胶原7S片段的关系
Hepatology. 1996 May;23(5):1154-8. doi: 10.1053/jhep.1996.v23.pm0008621148.
7
Metabolic function of the isolated perfused rat liver in chronic sepsis.慢性脓毒症中离体灌注大鼠肝脏的代谢功能
J Surg Res. 1995 Aug;59(2):287-91. doi: 10.1006/jsre.1995.1166.
8
[Porphyrin metabolism in chronic liver diseases].
Ter Arkh. 1994;66(2):17-21.
9
[Somatomedins (insulin-like growth factors), growth hormone and chronic liver disease].[生长调节素（胰岛素样生长因子）、生长激素与慢性肝病]
Ugeskr Laeger. 1990 Jul 9;152(28):2022-5.
10
[The catabolic products of the cell receptors in chronic liver diseases].[慢性肝病中细胞受体的分解代谢产物]
Klin Med (Mosk). 1996;74(2):46-8.

引用本文的文献

1
The Endothelium as a Driver of Liver Fibrosis and Regeneration.内皮细胞作为肝纤维化和再生的驱动因素。
Cells. 2020 Apr 10;9(4):929. doi: 10.3390/cells9040929.
2
The assessment and management of pain in cirrhosis.肝硬化疼痛的评估与管理
Curr Hepatol Rep. 2018 Mar;17(1):42-51. doi: 10.1007/s11901-018-0389-7. Epub 2018 Feb 22.
3
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity.患者特异性因素对肝脏药物反应和毒性的重要性。
Int J Mol Sci. 2016 Oct 12;17(10):1714. doi: 10.3390/ijms17101714.
4
Analgesics in patients with hepatic impairment: pharmacology and clinical implications.肝功能损害患者的镇痛药：药理学和临床意义。
Drugs. 2012 Aug 20;72(12):1645-69. doi: 10.2165/11635500-000000000-00000.
5
Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis.肝硬化大鼠单次静脉注射 dl-白屈菜红碱后的药代动力学。
Daru. 2011;19(3):210-5.
6
The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study).直肠臭氧对肝硬化门静脉氧合及普萘洛尔药代动力学的影响（初步人体研究）。
Br J Clin Pharmacol. 2011 Mar;71(3):411-5. doi: 10.1111/j.1365-2125.2010.03851.x.
7
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.肝功能不全患者的药代动力学及剂量调整
Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2.
8
Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.肝窦阻力增加是灌注肝硬化大鼠肝脏基础状态及内皮素诱导的静脉收缩的原因。
Pflugers Arch. 2008 Jun;456(3):467-77. doi: 10.1007/s00424-007-0437-6. Epub 2008 Jan 5.
9
Steady-state pharmacokinetics of roflumilast and roflumilast N-oxide in patients with mild and moderate liver cirrhosis.罗氟司特及N-氧化罗氟司特在轻度和中度肝硬化患者中的稳态药代动力学
Clin Pharmacokinet. 2007;46(5):403-16. doi: 10.2165/00003088-200746050-00003.
10
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.衰老和肝硬化中的肝血窦：对肝脏底物处置和药物清除的影响。
Clin Pharmacokinet. 2005;44(2):187-200. doi: 10.2165/00003088-200544020-00004.